Isabelle Rivière
5PUBLICATIONS
47CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 05, 2025
Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies.Sanam Shahid, Susan E Prockop, Georgia C Flynn
|Jan 30, 2025
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma.Jae H Park, M Lia Palomba, Karlo Perica
|Dec 04, 2024
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis.Eric M Jurgens, Ross S Firestone, Jagrutiben Chaudhari
|Mar 24, 2023
Programming CAR T Cell Tumor Recognition: Tuned Antigen Sensing and Logic Gating.Mohamad Hamieh, Jorge Mansilla-Soto, Isabelle Rivière
|Apr 14, 2021
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy.Kitsada Wudhikarn, Jessica R Flynn, Isabelle Rivière
Pageof 1
Frequent Collaborators
4 joint publications
Michel Sadelain
3 joint publications
Jae H Park
3 joint publications
Devin P McAvoy
2 joint publications
Michael Scordo
2 joint publications
Kinga Hosszu
2 joint publications
Gunjan Shah
2 joint publications
Sergio A Giralt
2 joint publications
Jorge Mansilla-Soto
2 joint publications
Sean M Devlin
1 joint publications
Jessica R Flynn
